Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Atia Vision
AddedFeb 15, 2024
UpdatedJun 18, 2026
Atia Vision

Atia Vision

Series B

Atia Medical Inc: A California-based medical innovation hub providing advanced devices.

HQ
Campbell, CA, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Atia Vision, a California-based medical innovation hub and part of the Shifamed portfolio, is dedicated to enhancing patient outcomes through advanced medical devices. The company focuses on developing a modular, shape-changing intraocular lens (IOL) known as the OmniVu™ IOL System, aimed at revolutionizing cataract and refractive surgery. Atia Vision's mission is to provide cutting-edge solutions that improve vision and overall quality of life for patients.

Atia Vision has made significant strides in the medical device industry, notably presenting first-in-human results of their OmniVu™ IOL System at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting. This achievement underscores their commitment to innovation and excellence in ophthalmology. The company's pioneering work has garnered attention within the medical community, positioning them as a leader in the development of advanced intraocular lenses.

Atia Vision - Similar Companies

RxSight logo

RxSight

rxsight.com

Sight Sciences logo

Sight Sciences

sightsciences.com

Ataia logo

Ataia

ataiamedical.com

Clearsight logo

Clearsight

Retina Technologies logo

Retina Technologies

AtaCor Medical logo

AtaCor Medical

atacor.com

ReaLens logo

ReaLens

Ativa Medical logo

Ativa Medical

Atrility Medical logo

Atrility Medical

atrility.com

PercuVision logo

PercuVision

ClarVista Medical logo

ClarVista Medical

STAAR Surgical logo

STAAR Surgical

staar.com

Omega Ophthalmics logo

Omega Ophthalmics

Iscience Surgical logo

Iscience Surgical

MicroOptx logo

MicroOptx

Atia Vision - Quick Facts

Who are Atia Vision's competitors?

Companies similar to Atia Vision include RxSight, Sight Sciences, Ataia and Clearsight.

When was Atia Vision founded?

Atia Vision was founded in 2012.

Where is Atia Vision's headquarters located?

Atia Vision's headquarters is located in Campbell, CA, US.

When was Atia Vision's last funding round?

Atia Vision's most recent funding round was for $28.6M (USD) in August 2022.

How much has Atia Vision raised to-date?

As of Aug 22, 2022, Atia Vision has raised a total of $111.1M (USD).

How many employees does Atia Vision have?

Atia Vision has 29 employees as of Feb 5, 2024.

Atia Vision - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified